NO20005400L - Kinoloner anvendt som MRS-inhibitorer og baktericider - Google Patents

Kinoloner anvendt som MRS-inhibitorer og baktericider

Info

Publication number
NO20005400L
NO20005400L NO20005400A NO20005400A NO20005400L NO 20005400 L NO20005400 L NO 20005400L NO 20005400 A NO20005400 A NO 20005400A NO 20005400 A NO20005400 A NO 20005400A NO 20005400 L NO20005400 L NO 20005400L
Authority
NO
Norway
Prior art keywords
bactericides
inhibitors
mrs
quinolones
quinolones used
Prior art date
Application number
NO20005400A
Other languages
English (en)
Other versions
NO20005400D0 (no
Inventor
John Michael Berge
John Stephen Elder
Dieter Wolfgang Hamprecht
David Jonathan Mcnair
Pamela Brown
Andrew Keith Forrest
Richard Lewis Jarvest
Robert John Sheppard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9809050.9A external-priority patent/GB9809050D0/en
Priority claimed from GBGB9824571.5A external-priority patent/GB9824571D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005400L publication Critical patent/NO20005400L/no
Publication of NO20005400D0 publication Critical patent/NO20005400D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Forbindelser med formel (I) er inhibitorer av det bakterielle enzym S aurens metionyl-tRNA-syntetase og er anvendelig i behandling av bakterielle infeksjoner.
NO20005400A 1998-04-29 2000-10-26 Kinoloner anvendt som MRS-inhibitorer og baktericider NO20005400D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9809050.9A GB9809050D0 (en) 1998-04-29 1998-04-29 Novel compounds
GBGB9824571.5A GB9824571D0 (en) 1998-11-09 1998-11-09 Novel compounds
PCT/EP1999/002648 WO1999055677A1 (en) 1998-04-29 1999-04-15 Quinolones used as mrs inhibitors and bactericides

Publications (2)

Publication Number Publication Date
NO20005400L true NO20005400L (no) 2000-10-26
NO20005400D0 NO20005400D0 (no) 2000-10-26

Family

ID=26313554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005400A NO20005400D0 (no) 1998-04-29 2000-10-26 Kinoloner anvendt som MRS-inhibitorer og baktericider

Country Status (16)

Country Link
US (1) US6320051B1 (no)
EP (1) EP1084110A1 (no)
JP (1) JP2002513005A (no)
KR (1) KR20010043131A (no)
CN (1) CN1307565A (no)
AR (1) AR018199A1 (no)
AU (1) AU3523599A (no)
BR (1) BR9909994A (no)
CA (1) CA2330564A1 (no)
CO (1) CO5080763A1 (no)
HU (1) HUP0103093A3 (no)
IL (1) IL138906A0 (no)
NO (1) NO20005400D0 (no)
PL (1) PL343680A1 (no)
TR (1) TR200003170T2 (no)
WO (1) WO1999055677A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040014121A1 (en) * 1996-04-18 2004-01-22 Smithkline Beecham Corporation Novel compounds
GB9822241D0 (en) * 1998-10-12 1998-12-09 Smithkline Beecham Plc Novel compounds
GB9827467D0 (en) * 1998-12-15 1999-02-10 Zeneca Ltd Chemical compounds
EP1466603A3 (en) * 1999-05-05 2004-10-20 Merck & Co., Inc. Novel catechols as antimicrobial agents
ES2226839T3 (es) * 1999-05-05 2005-04-01 MERCK & CO., INC. Nuevos catecoles como agentes antimicrobianos.
WO2000071524A1 (en) * 1999-05-19 2000-11-30 Smithkline Beecham Plc 2-nh-pyridones and pyrimidones as mrs inhibitors
GB9911594D0 (en) * 1999-05-19 1999-07-21 Smithkline Beecham Plc Novel compounds
AU2002226048A1 (en) * 2000-12-11 2002-06-24 Smith Kline Beecham Corporation Urotensin-ii receptor antagonists
AU2002239506A1 (en) * 2000-12-11 2002-06-24 Smith Kline Beecham Corporation Urotensin-ii receptor antagonists
JP2004524295A (ja) * 2001-01-26 2004-08-12 スミスクライン・ビーチャム・コーポレイション ウロテンシン−ｉｉ受容体アンタゴニスト
SE0202134D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Therapeutic agents
CA2509413C (en) 2002-12-20 2012-05-01 Glaxo Group Limited Benzazepine derivatives for the treatment of neurological disorders
CA2517523A1 (en) 2003-03-03 2004-09-16 Replidyne, Inc. Substituted thiophenes with antibacterial activity
GB0304809D0 (en) * 2003-03-03 2003-04-09 Glaxo Group Ltd Novel compounds
WO2005009336A2 (en) * 2003-05-01 2005-02-03 Replidyne, Inc. Antibacterial methods and compositions
WO2005066132A1 (en) * 2004-01-07 2005-07-21 Astrazeneca Ab Therapeutic agents i
JO3077B1 (ar) * 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
US7994192B2 (en) 2006-09-26 2011-08-09 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8658670B2 (en) 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
US7973050B2 (en) 2006-09-26 2011-07-05 Crestone, Inc. Enantiomeric compounds with antibacterial activity
WO2008039639A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity
US8697720B2 (en) 2006-09-26 2014-04-15 Crestone, Inc. Substituted phenylether-thienopyridone compounds with antibacterial activity
WO2008039640A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Enantiomeric compounds with antibacterial activity
CN104546857B (zh) * 2013-10-18 2017-01-04 北京北科德源生物医药科技有限公司 化合物naphthoylenequinazolone的抗菌用途
WO2018178041A1 (en) * 2017-03-30 2018-10-04 F. Hoffmann-La Roche Ag Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
CN110724097B (zh) * 2019-11-11 2021-03-09 山东畜牧兽医职业学院 一种治疗耐药性微生物菌的化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
KR950005301B1 (ko) * 1990-09-04 1995-05-23 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
KR960007566A (ko) * 1994-08-19 1996-03-22 김정규 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도

Also Published As

Publication number Publication date
BR9909994A (pt) 2000-12-26
EP1084110A1 (en) 2001-03-21
AR018199A1 (es) 2001-10-31
CN1307565A (zh) 2001-08-08
AU3523599A (en) 1999-11-16
IL138906A0 (en) 2001-11-25
PL343680A1 (en) 2001-08-27
US6320051B1 (en) 2001-11-20
KR20010043131A (ko) 2001-05-25
CA2330564A1 (en) 1999-11-04
HUP0103093A3 (en) 2002-03-28
CO5080763A1 (es) 2001-09-25
JP2002513005A (ja) 2002-05-08
TR200003170T2 (tr) 2001-01-22
HUP0103093A2 (hu) 2002-02-28
NO20005400D0 (no) 2000-10-26
WO1999055677A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
NO20005400L (no) Kinoloner anvendt som MRS-inhibitorer og baktericider
ATE433963T1 (de) Fab-i inhibitoren
GB9917408D0 (en) Compounds
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
CA2400554A1 (en) Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
MY138797A (en) Bacterial gyrase inhibitors and uses thereof
CY1112442T1 (el) Παραγωγα πυριδινονης για θεραπεια αθηροσκληρωσης
TR200103216T2 (tr) Pirimidinon bileşimleri
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
ID22042A (id) Benzonaftiridin sebagai pengobatan cabang tenggorokan
NO996108L (no) 9-oksinerytromycinderivater
SE9803518D0 (sv) Novel compounds
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
DE69913712T2 (de) Inhibitoren der bakteriellen nad synthetase
DK0920426T3 (da) Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
SE9803773D0 (sv) Compounds
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
DK0808326T3 (da) Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
DE60202669D1 (de) 6-phenylbenzonaphthyidine
TR200100133T2 (tr) FKBP İnhibitörleri
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application